Collecting health data from NHLBI patients and donors
Part of Blood & lymphatic, Cancer clinical trials.
This study collects information about standard care for people seen by the NHLBI, and also about donors. It helps researchers understand what happens in real-world care, which can improve future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a patient seen in an NHLBI-related program, or a stem cell donor
- Your parent/guardian can sign consent if you are under 18
- You (or your legally authorized representative) can understand the study and sign consent
- You are at least 2 years old
- Your weight is more than 12 kilograms
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects and stores tumor and blood samples from children and young adults with cancer, blood disorders, or immune conditions. The samples are used to better understand these diseases and could help future treatments.
This study is a general screening step at the NIH Clinical Center to check whether you might qualify for other NHLBI research protocols. It helps match you (or a donor/healthy volunteer) to the right study and confirms you can consent to participate.
This study collects tissue samples from patients with cancer or blood disorders, and from their matching family members who might donate stem cells for transplant. The samples help researchers understand these diseases and develop better treatments.
This study collects and stores biological samples (like blood and cord blood) to help researchers understand what causes disease. You may be asked to provide samples during pregnancy, delivery, or from an affected person, depending on eligibility.
This study collects human samples (like blood or other specimens) to learn more about hairy cell leukemia and other leukemias. It also helps researchers develop new lab-made immune-based medicines for cancer treatment.
This study asks healthy adults to provide blood, bone marrow (if needed), skin, saliva, and stool samples. Scientists use these samples to compare patterns related to myeloid (bone-marrow) blood cancers, which may help future research and tests.
Hear when a new Hematologic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.